IP Library Assignment 024630/0384
Patent Assignment
Reel/Frame 024630/0384

Corrective Assignment to Correct the Address of the Receiving Party as Listed on the Patent Assignment Cover Sheet Attached Hereto and Previously Recorded on Reel 023985 Frame 0502. Assignor(S) Hereby Confirms the Correct Address of the Receiving Party Is 7-1-27, Ameerpet, Hyderabad-500016, India..

Recorded: 2010-07-06 Pages: 15
Assignor
REDDY US THERAPEUTICS, INC.
Executed: 2010-02-05
Assignee
DR. REDDY'S LABORATORIES LTD.
7-1-27, AMEERPET, HYDERABAD, 500016, INDIA
Covered Properties (54)
Novel Benzylamine Derivatives as Cetp Inhibitors
Selective Benzylamine Derivatives and Their Utility as Cholesterol Ester-Transfer Protein Inhibitors
Methods and Compositions for the Treatment of Insulin Resistance, Diabetes, and Diabetes-Associated Dyslipidemia
Compositions and Methods to Enhance Reverse Cholesterol Transport
Methods and Compositions for Upregulation of Peroxiredoxin Activity
Methods and Compositions for Upregulation of Gata Activity
Novel Biccyclic Compounds as Gata Modulators
Novel Heterocyclic Compounds as Gata Modulators
Methods and Compositions for Glycosidase Assays
Patent: 6,656,699 →
Application: 09/952,648 →
Publication: US 2002/0064806
Methods and Compositions for the Treatment of Inflammatory Diseases
Patent: 6,900,041 →
Application: 09/969,013 →
Publication: US 2002/0077293
Methods and compositions of novel triazine compounds
Application: 10/253,388 →
Methods and Compositions of Novel Triazine Compounds
Patent: 7,173,032 →
Application: 10/390,485 →
Publication: US 2004/0077648
Methods and Compositions of Novel Triazine Compounds
Patent: 7,163,943 →
Application: 10/397,968 →
Publication: US 2004/0209880
Methods and Compositions of Novel Triazine Compounds
Patent: 7,112,587 →
Application: 10/400,134 →
Publication: US 2004/0209881
Methods and Compositions of Novel Triazine Compounds
Patent: 7,132,423 →
Application: 10/400,140 →
Publication: US 2004/0224950
Methods and Compositions of Novel Triazine Compounds
Patent: 7,169,785 →
Application: 10/400,169 →
Publication: US 2004/0209882
Triazine Compounds and Their Analogs, Compositions, and Methods
Patent: 7,335,770 →
Application: 10/808,210 →
Publication: US 2005/0227983
Medical Devices Employing Triazine Compounds and Compositions Thereof
Patent: 7,238,692 →
Application: 10/951,120 →
Publication: US 2005/0124619
Medical Devices Employing Triazine Compounds and Compositions Thereof
Patent: 7,268,134 →
Application: 10/951,305 →
Publication: US 2005/0113341
Medical Devices Employing Triazine Compounds and Compositions Thereof
Patent: 7,169,784 →
Application: 10/951,316 →
Publication: US 2005/0137196
Heterocyclic Compounds and Methods of Making and Using Thereof
Patent: 7,456,288 →
Application: 10/976,284 →
Publication: US 2005/0119269
Novel Pyridine Compounds, Process for Their Preparation and Compositions Containing Them
Patent: 7,622,486 →
Application: 11/234,257 →
Publication: US 2006/0084644
Novel Pyrimidine Compounds, Process for Their Preparation and Compositions Containing Them
Patent: 7,820,654 →
Application: 11/234,695 →
Publication: US 2006/0084645
Methods and Compositions of Novel Triazine Compounds
Patent: 7,265,114 →
Application: 11/284,757 →
Publication: US 2006/0172984
Substituted Pyrazolo[4,3-d]pyrimidines as Anti-inflammatory Agents
Application: 11/285,982 →
Publication: US 2006/0128729
Novel Heterocyclic Compounds and Their Pharmaceutical Compositions
Patent: 7,700,774 →
Application: 11/314,299 →
Publication: US 2006/0135551
Substituted Benzylamino Quinolines as Cholesterol Ester-Transfer Protein Inhibitors
Patent: 9,040,558 →
Application: 11/320,120 →
Publication: US 2006/0178514
Methods and Compositions of Novel Triazine Compounds
Patent: 7,332,490 →
Application: 11/441,326 →
Publication: US 2006/0258641
Substituted Benzylamino Quinolines as Cholesterol Ester-Transfer Protein Inhibitors
Patent: 8,604,055 →
Application: 11/478,547 →
Publication: US 2007/0015758
Methods and Compositions of Novel Triazine Compounds
Patent: 7,332,488 →
Application: 11/511,129 →
Publication: US 2007/0117795
Medical Devices Employing Triazine Compounds and Compositions Thereof
Patent: 7,335,656 →
Application: 11/512,863 →
Publication: US 2007/0122444
Use of Biomarkers of Inflammation as Indicators of Drug Efficacy
Application: 11/753,951 →
Publication: US 2008/0089843
Compositions and Methods to Enhance Reverse Cholesterol Transport
Application: 11/759,713 →
Publication: US 2008/0119571
Methods and Compositions for Upregulation of GATA Activity
Application: 12/113,426 →
Publication: US 2008/0275049
Methods and Compositions for Upregulation of Peroxiredoxin Activity
Application: 12/441,924 →
Publication: US 2010/0297673
Novel Heterocyclic Compounds as Gata Modulators
Application: 12/553,623 →
Publication: US 2010/0144722
Novel Biccyclic Compounds as Gata Modulators
Patent: 7,989,463 →
Application: 12/553,694 →
Publication: US 2010/0144731
Methods and compositions for glycosidase assays
Application: 60/233,075 →
Methods and compositions for the treatment of inflammatory diseases
Application: 60/237,147 →
Methods and compositions for novel chemical compounds
Application: 60/324,147 →
Methods and compositions of novel heterocyclic compounds
Application: 60/610,163 →
Novel heterocyclic compounds, process for their preparation and compositions containing them
Application: 60/612,374 →
Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
Application: 60/630,604 →
Novel tetrahydro-quinoline compounds and their pharmaceutical compositions
Application: 60/638,084 →
Novel benzylamine derivatives as CETP inhibitors
Application: 60/640,798 →
Use of biomarkers of inflammation as indicators of drug efficacy
Application: 60/808,396 →
Compositions and methods to enhance reverse cholesterol transport
Application: 60/811,669 →
Combination Therapy of Niacin and Non-Steroidal Anti-Inflammatory Agents for Treatment of Low Hdl and Cardiovascular Disease
Application: 60/886,113 →
Methods and Compositions for Upregulation of GATA Activity
Application: 60/916,214 →
Methods and Compositions for Upregulation of Peroxiredoxin Activity
Application: 60/951,801 →
Methods and Compositions for the Treatment of Insulin Resistance, Diabetes, and Diabetes-Associated Dyslipidemia
Application: 60/986,002 →
Novel cyclopentapyrimidine compounds
Application: 61/190,814 →
Novel pyrimidine compounds
Application: 61/190,836 →
Balaglitazone-Containing Compositions and Methods
Application: 61/287,821 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 29, 2002
From: CAHOON, SHIANLEN; PILLARISETTI, SIVRAM; SAXENA, UDAY; VINES, ANGELA
To: REDDY US THERAPEUTICS, INC.
Reel/Frame 012538/0561 →
Assignment of Assignor's Interest Nov 13, 2002
From: TIMMER, RICHARD T.; ALEXANDER, CHRISTOPHER W.; PILLARISETTI, SIVARAM; SAXENA, UDAY
To: REDDY US THERAPEUTICS, INC.
Reel/Frame 013483/0714 →
Assignment of Assignor's Interest Jun 12, 2003
From: PILLARISETTI, SIVARAM; SAXENA, UDAY; WANG, DONGYAN
To: REDDY US THERAPEUTICS, INC.
Reel/Frame 014165/0330 →
Assignment of Assignor's Interest Dec 8, 2003
From: TIMMER, RICHARD T.; ALEXANDER, CHRISTOPHER W.; PILLARISETTI, SIVARAM; SAXENA, UDAY
To: REDDY US THERAPEUTICS, INC.
Reel/Frame 014793/0556 →
Assignment of Assignor's Interest Dec 15, 2003
From: TIMMER, RICHARD T.; ALEXANDER, CHRISTOPHER W.; PILLARISETTI, SIVARAM; SAXENA, UDAY
To: REDDY US THERAPEUTICS, INC.
Reel/Frame 014784/0154 →
Assignment of Assignor's Interest Dec 15, 2003
From: TIMMER, RICHARD T.; ALEXANDER, CHRISTOPHER W.; PILLARISETTI, SIVARAM; SAXENA, UDAY
To: REDDY US THERAPEUTICS, INC.
Reel/Frame 014783/0868 →
Assignment of Assignor's Interest Jun 24, 2005
From: TIMMER, RICHARD T.; ALEXANDER, CHRISTOPHER W.; PILLARISETTI, SIVARAM; SAXENA, UDAY
To: REDDY US THERAPEUTICS, INC.
Reel/Frame 016404/0307 →
Assignment of Assignor's Interest Feb 25, 2010
From: REDDY US THERAPEUTICS, INC.
To: DR. REDDY'S LABORATORIES LTD.
Reel/Frame 023985/0502 →